N J L M

 
Subscribe Via RSS
  • Home
  • About
    Salient Features Bibliographic Information Abstracting and Indexing Specialties Covered Publisher
  • Issues
    Current Issue Online Ahead of Print Archive Forthcoming issue
  • Editorial
    Editorial Statements Editorial-PeerReview Process Editorial Board Publication Ethics & Malpractice Join us
  • Authors
    Submit an Article Manuscript Instructions Manuscript Assistance Publication Charges Paid Services Early Online Publication Service
  • Reviewers
    Apply as Reviewer Reviewers Acknowledgment
  • Search
    Simple Search Advanced Search
  • Member
    Register Login
  • Contact
  • Subscription
Original article / research
Year : 2023 Month : July-September Volume : 12 Issue : 3 Page : MO11 - MO14

Detection of Carbapenemase Production by Modified Carbapenem Inactivation Method among Carbapenem Resistant Gram-negative Bacilli at a Tertiary Care Centre in Coimbatore, Tamil Nadu, India

 
Correspondence Address :
Lavanya Jeyamani,
C2 Gee Kay Classic Apartment, Thottipalayam Piruvu, Coimbatore, Tamil Nadu, India.
E-mail: jlavanya152@gmail.com
Introduction: In the era of increasing antimicrobial resistance, knowing the mechanism of carbapenem resistance can aid in choosing an apt drug for treatment of patients. There are only few studies estimating the burden of carbapenem resistance and determining the mechanism of resistance among the isolates in our locale.

Aim: To determine the prevalence of carbapenemase production by modified Carbapenem Inactivation Method (mCIM) among the Carbapenem Resistant Gram-Negative Bacteria (CRGNB)- Enterobacteriaceae and Pseudomonas aeruginosa isolated in our hospital.

Materials and Methods: This was a prospective observational study conducted in Department of Microbiology, KMCH, Coimbatore, Tamil Nadu, India during the period of June 2021 to August 2021. A total of 165 isolates of Enterobacteriaceae family and P. aeruginosa which were resistant to one of the carbapenems (imipenem, meropenem or ertapenem) by Vitek MIC testing were included in the study. All were subjected to mCIM and EDTA-modified CIM (eCIM) test and interpreted as per the CLSI M100 S31 guidelines.

Results: Among the 165 isolates, 130 (78.8%) were K. pneumoniae, 27 (16.4%) were other Enterobacteriaceae and eight (4.8%) were P. aeruginosa. Prevalence of mCIM positivity was 51.5% (85 isolates). Approximately, 98% of the mCIM positives (Carbapenemase Producing Gram-Negative Bacteria [CPGNB]) were eCIM positive indicating Metallo-Beta-Lactamase (MBL) production.

Conclusion: Performing mCIM in CRGNB is important in routine practice to identify CPGNBs. Due to very high prevalence of MBL among carbapenemase producers, it is advisable to choose ceftazidime avibactam plus aztreonam as the treatment option for CPGNB in our locale.
 
[ FULL TEXT ]   |   [ ]
 
  • Article Utilities

    • Readers Comments (0)
    • Article in PDF
    • Citation Manager
    • Article Statistics
    • Link to PUBMED
    • Print this Article
    • Send to a Friend
  • Go To Issues

    • Current Issue
    • Past Issues
  • Search Articles

    • Simple Search
    • Advance Search
  • Authors Facilities

    • Extensive Author Support
    • Submit Manuscript
    • ONLINE First Facility
    • NJLM Pre Publishing
  • Quick Links

    • REVIEWER
    • ACCESS STATISTICS
  • Users

    • Register
    • Log in
  • Pages

    • About
    • Issues
    • Editorials
    • Authors
    • Reviewers
    • Search
    • Contacts
  • Issues Archives

  • Affiliated Websites

    • JCDR Prepublishing
    • Neonatal Database Home
    • JCDR Neonatal Database download center